 | • レポートコード：QYR2104Z4876 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、Q熱のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（急性Q熱、慢性Q熱）、用途別市場規模（病院＆診療所、診断センター、手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・Q熱の市場動向 ・企業の競争状況、市場シェア ・Q熱の種類別市場規模（急性Q熱、慢性Q熱） ・Q熱の用途別市場規模（病院＆診療所、診断センター、手術センター） ・Q熱の北米市場規模2016-2027（アメリカ、カナダ） ・Q熱のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・Q熱のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・Q熱の中南米市場規模2016-2027（メキシコ、ブラジル） ・Q熱の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Yashica Pharmaceuticals Private Limited (India)、Merck & Co. (US)、Atox Bio (Israel)、Teva Pharmaceutical Industries (Israel)、Basilea Pharmaceutica Ltd. (Switzerland)、MELINTA THERAPEUTICS(US)、Pfizer (US)、Cipla Inc. (India)） ・結論 |
Q fever is a mild disease with flu-like symptoms. Many patients have no symptoms at all while in some cases; the infection can reoccur/resurface years later. The chronic Q fever is a more deadly form of Q fever which may damage heart, liver, brain, lungs and can cause diabetes in some cases.
The Americas account for the largest share in the global Q fever market owing to the presence of key players in the market and rising emphasis on diagnosis and treatment of rare diseases. Furthermore, the rising awareness about bacterial infection further accelerates the growth of the market. North America is the accounted for the highest market share in this region with the U.S. being the largest market followed by Canada. In the U.S, the prevalence of cardiovascular disease is found to be increasing from last few years. This is attributed to the rising prevalence of chronic diseases such as obesity and diabetes which are major risk factors for cardiovascular diseases.
Market Analysis and Insights: Global Q Fever Market
The global Q Fever market size is projected to reach US$ 5993.9 million by 2026, from US$ 4407.2 million in 2019, at a CAGR of 4.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Q Fever market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Q Fever market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Q Fever market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Q Fever market.
Global Q Fever Scope and Market Size
Q Fever market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Q Fever market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Acute Q Fever
Chronic Q Fever
Segment by Application
Hospitals & Clinics
Diagnostic Centers
Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Yashica Pharmaceuticals Private Limited (India)
Merck & Co. (US)
Atox Bio (Israel)
Teva Pharmaceutical Industries (Israel)
Basilea Pharmaceutica Ltd. (Switzerland)
MELINTA THERAPEUTICS(US)
Pfizer (US)
Cipla Inc. (India)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Q Fever Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acute Q Fever
1.2.3 Chronic Q Fever
1.3 Market by Application
1.3.1 Global Q Fever Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinics
1.3.3 Diagnostic Centers
1.3.4 Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Q Fever Market Perspective (2016-2027)
2.2 Q Fever Growth Trends by Regions
2.2.1 Q Fever Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Q Fever Historic Market Share by Regions (2016-2021)
2.2.3 Q Fever Forecasted Market Size by Regions (2022-2027)
2.3 Q Fever Industry Dynamic
2.3.1 Q Fever Market Trends
2.3.2 Q Fever Market Drivers
2.3.3 Q Fever Market Challenges
2.3.4 Q Fever Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Q Fever Players by Revenue
3.1.1 Global Top Q Fever Players by Revenue (2016-2021)
3.1.2 Global Q Fever Revenue Market Share by Players (2016-2021)
3.2 Global Q Fever Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Q Fever Revenue
3.4 Global Q Fever Market Concentration Ratio
3.4.1 Global Q Fever Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Q Fever Revenue in 2020
3.5 Q Fever Key Players Head office and Area Served
3.6 Key Players Q Fever Product Solution and Service
3.7 Date of Enter into Q Fever Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Q Fever Breakdown Data by Type
4.1 Global Q Fever Historic Market Size by Type (2016-2021)
4.2 Global Q Fever Forecasted Market Size by Type (2022-2027)
5 Q Fever Breakdown Data by Application
5.1 Global Q Fever Historic Market Size by Application (2016-2021)
5.2 Global Q Fever Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Q Fever Market Size (2016-2027)
6.2 North America Q Fever Market Size by Type
6.2.1 North America Q Fever Market Size by Type (2016-2021)
6.2.2 North America Q Fever Market Size by Type (2022-2027)
6.2.3 North America Q Fever Market Size by Type (2016-2027)
6.3 North America Q Fever Market Size by Application
6.3.1 North America Q Fever Market Size by Application (2016-2021)
6.3.2 North America Q Fever Market Size by Application (2022-2027)
6.3.3 North America Q Fever Market Size by Application (2016-2027)
6.4 North America Q Fever Market Size by Country
6.4.1 North America Q Fever Market Size by Country (2016-2021)
6.4.2 North America Q Fever Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Q Fever Market Size (2016-2027)
7.2 Europe Q Fever Market Size by Type
7.2.1 Europe Q Fever Market Size by Type (2016-2021)
7.2.2 Europe Q Fever Market Size by Type (2022-2027)
7.2.3 Europe Q Fever Market Size by Type (2016-2027)
7.3 Europe Q Fever Market Size by Application
7.3.1 Europe Q Fever Market Size by Application (2016-2021)
7.3.2 Europe Q Fever Market Size by Application (2022-2027)
7.3.3 Europe Q Fever Market Size by Application (2016-2027)
7.4 Europe Q Fever Market Size by Country
7.4.1 Europe Q Fever Market Size by Country (2016-2021)
7.4.2 Europe Q Fever Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Q Fever Market Size (2016-2027)
8.2 Asia-Pacific Q Fever Market Size by Type
8.2.1 Asia-Pacific Q Fever Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Q Fever Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Q Fever Market Size by Type (2016-2027)
8.3 Asia-Pacific Q Fever Market Size by Application
8.3.1 Asia-Pacific Q Fever Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Q Fever Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Q Fever Market Size by Application (2016-2027)
8.4 Asia-Pacific Q Fever Market Size by Region
8.4.1 Asia-Pacific Q Fever Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Q Fever Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Q Fever Market Size (2016-2027)
9.2 Latin America Q Fever Market Size by Type
9.2.1 Latin America Q Fever Market Size by Type (2016-2021)
9.2.2 Latin America Q Fever Market Size by Type (2022-2027)
9.2.3 Latin America Q Fever Market Size by Type (2016-2027)
9.3 Latin America Q Fever Market Size by Application
9.3.1 Latin America Q Fever Market Size by Application (2016-2021)
9.3.2 Latin America Q Fever Market Size by Application (2022-2027)
9.3.3 Latin America Q Fever Market Size by Application (2016-2027)
9.4 Latin America Q Fever Market Size by Country
9.4.1 Latin America Q Fever Market Size by Country (2016-2021)
9.4.2 Latin America Q Fever Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Q Fever Market Size (2016-2027)
10.2 Middle East & Africa Q Fever Market Size by Type
10.2.1 Middle East & Africa Q Fever Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Q Fever Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Q Fever Market Size by Type (2016-2027)
10.3 Middle East & Africa Q Fever Market Size by Application
10.3.1 Middle East & Africa Q Fever Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Q Fever Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Q Fever Market Size by Application (2016-2027)
10.4 Middle East & Africa Q Fever Market Size by Country
10.4.1 Middle East & Africa Q Fever Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Q Fever Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Yashica Pharmaceuticals Private Limited (India)
11.1.1 Yashica Pharmaceuticals Private Limited (India) Company Details
11.1.2 Yashica Pharmaceuticals Private Limited (India) Business Overview
11.1.3 Yashica Pharmaceuticals Private Limited (India) Q Fever Introduction
11.1.4 Yashica Pharmaceuticals Private Limited (India) Revenue in Q Fever Business (2016-2021)
11.1.5 Yashica Pharmaceuticals Private Limited (India) Recent Development
11.2 Merck & Co. (US)
11.2.1 Merck & Co. (US) Company Details
11.2.2 Merck & Co. (US) Business Overview
11.2.3 Merck & Co. (US) Q Fever Introduction
11.2.4 Merck & Co. (US) Revenue in Q Fever Business (2016-2021)
11.2.5 Merck & Co. (US) Recent Development
11.3 Atox Bio (Israel)
11.3.1 Atox Bio (Israel) Company Details
11.3.2 Atox Bio (Israel) Business Overview
11.3.3 Atox Bio (Israel) Q Fever Introduction
11.3.4 Atox Bio (Israel) Revenue in Q Fever Business (2016-2021)
11.3.5 Atox Bio (Israel) Recent Development
11.4 Teva Pharmaceutical Industries (Israel)
11.4.1 Teva Pharmaceutical Industries (Israel) Company Details
11.4.2 Teva Pharmaceutical Industries (Israel) Business Overview
11.4.3 Teva Pharmaceutical Industries (Israel) Q Fever Introduction
11.4.4 Teva Pharmaceutical Industries (Israel) Revenue in Q Fever Business (2016-2021)
11.4.5 Teva Pharmaceutical Industries (Israel) Recent Development
11.5 Basilea Pharmaceutica Ltd. (Switzerland)
11.5.1 Basilea Pharmaceutica Ltd. (Switzerland) Company Details
11.5.2 Basilea Pharmaceutica Ltd. (Switzerland) Business Overview
11.5.3 Basilea Pharmaceutica Ltd. (Switzerland) Q Fever Introduction
11.5.4 Basilea Pharmaceutica Ltd. (Switzerland) Revenue in Q Fever Business (2016-2021)
11.5.5 Basilea Pharmaceutica Ltd. (Switzerland) Recent Development
11.6 MELINTA THERAPEUTICS(US)
11.6.1 MELINTA THERAPEUTICS(US) Company Details
11.6.2 MELINTA THERAPEUTICS(US) Business Overview
11.6.3 MELINTA THERAPEUTICS(US) Q Fever Introduction
11.6.4 MELINTA THERAPEUTICS(US) Revenue in Q Fever Business (2016-2021)
11.6.5 MELINTA THERAPEUTICS(US) Recent Development
11.7 Pfizer (US)
11.7.1 Pfizer (US) Company Details
11.7.2 Pfizer (US) Business Overview
11.7.3 Pfizer (US) Q Fever Introduction
11.7.4 Pfizer (US) Revenue in Q Fever Business (2016-2021)
11.7.5 Pfizer (US) Recent Development
11.8 Cipla Inc. (India)
11.8.1 Cipla Inc. (India) Company Details
11.8.2 Cipla Inc. (India) Business Overview
11.8.3 Cipla Inc. (India) Q Fever Introduction
11.8.4 Cipla Inc. (India) Revenue in Q Fever Business (2016-2021)
11.8.5 Cipla Inc. (India) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Q Fever Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acute Q Fever
Table 3. Key Players of Chronic Q Fever
Table 4. Global Q Fever Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Q Fever Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Q Fever Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Q Fever Market Share by Regions (2016-2021)
Table 8. Global Q Fever Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Q Fever Market Share by Regions (2022-2027)
Table 10. Q Fever Market Trends
Table 11. Q Fever Market Drivers
Table 12. Q Fever Market Challenges
Table 13. Q Fever Market Restraints
Table 14. Global Q Fever Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Q Fever Market Share by Players (2016-2021)
Table 16. Global Top Q Fever Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Q Fever as of 2020)
Table 17. Ranking of Global Top Q Fever Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Q Fever Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Q Fever Product Solution and Service
Table 21. Date of Enter into Q Fever Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Q Fever Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Q Fever Revenue Market Share by Type (2016-2021)
Table 25. Global Q Fever Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Q Fever Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Q Fever Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Q Fever Revenue Market Share by Application (2016-2021)
Table 29. Global Q Fever Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Q Fever Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Q Fever Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Q Fever Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Q Fever Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Q Fever Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Q Fever Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Q Fever Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Q Fever Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Q Fever Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Q Fever Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Q Fever Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Q Fever Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Q Fever Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Q Fever Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Q Fever Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Q Fever Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Q Fever Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Q Fever Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Q Fever Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Q Fever Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Q Fever Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Q Fever Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Q Fever Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Q Fever Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Q Fever Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Q Fever Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Q Fever Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Q Fever Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Q Fever Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Q Fever Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Q Fever Market Size by Country (2022-2027) & (US$ Million)
Table 61. Yashica Pharmaceuticals Private Limited (India) Company Details
Table 62. Yashica Pharmaceuticals Private Limited (India) Business Overview
Table 63. Yashica Pharmaceuticals Private Limited (India) Q Fever Product
Table 64. Yashica Pharmaceuticals Private Limited (India) Revenue in Q Fever Business (2016-2021) & (US$ Million)
Table 65. Yashica Pharmaceuticals Private Limited (India) Recent Development
Table 66. Merck & Co. (US) Company Details
Table 67. Merck & Co. (US) Business Overview
Table 68. Merck & Co. (US) Q Fever Product
Table 69. Merck & Co. (US) Revenue in Q Fever Business (2016-2021) & (US$ Million)
Table 70. Merck & Co. (US) Recent Development
Table 71. Atox Bio (Israel) Company Details
Table 72. Atox Bio (Israel) Business Overview
Table 73. Atox Bio (Israel) Q Fever Product
Table 74. Atox Bio (Israel) Revenue in Q Fever Business (2016-2021) & (US$ Million)
Table 75. Atox Bio (Israel) Recent Development
Table 76. Teva Pharmaceutical Industries (Israel) Company Details
Table 77. Teva Pharmaceutical Industries (Israel) Business Overview
Table 78. Teva Pharmaceutical Industries (Israel) Q Fever Product
Table 79. Teva Pharmaceutical Industries (Israel) Revenue in Q Fever Business (2016-2021) & (US$ Million)
Table 80. Teva Pharmaceutical Industries (Israel) Recent Development
Table 81. Basilea Pharmaceutica Ltd. (Switzerland) Company Details
Table 82. Basilea Pharmaceutica Ltd. (Switzerland) Business Overview
Table 83. Basilea Pharmaceutica Ltd. (Switzerland) Q Fever Product
Table 84. Basilea Pharmaceutica Ltd. (Switzerland) Revenue in Q Fever Business (2016-2021) & (US$ Million)
Table 85. Basilea Pharmaceutica Ltd. (Switzerland) Recent Development
Table 86. MELINTA THERAPEUTICS(US) Company Details
Table 87. MELINTA THERAPEUTICS(US) Business Overview
Table 88. MELINTA THERAPEUTICS(US) Q Fever Product
Table 89. MELINTA THERAPEUTICS(US) Revenue in Q Fever Business (2016-2021) & (US$ Million)
Table 90. MELINTA THERAPEUTICS(US) Recent Development
Table 91. Pfizer (US) Company Details
Table 92. Pfizer (US) Business Overview
Table 93. Pfizer (US) Q Fever Product
Table 94. Pfizer (US) Revenue in Q Fever Business (2016-2021) & (US$ Million)
Table 95. Pfizer (US) Recent Development
Table 96. Cipla Inc. (India) Company Details
Table 97. Cipla Inc. (India) Business Overview
Table 98. Cipla Inc. (India) Revenue in Q Fever Business (2016-2021) & (US$ Million)
Table 99. Cipla Inc. (India) Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Q Fever Market Share by Type: 2020 VS 2027
Figure 2. Acute Q Fever Features
Figure 3. Chronic Q Fever Features
Figure 4. Global Q Fever Market Share by Application: 2020 VS 2027
Figure 5. Hospitals & Clinics Case Studies
Figure 6. Diagnostic Centers Case Studies
Figure 7. Surgical Centers Case Studies
Figure 8. Q Fever Report Years Considered
Figure 9. Global Q Fever Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Q Fever Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Q Fever Market Share by Regions: 2020 VS 2027
Figure 12. Global Q Fever Market Share by Regions (2022-2027)
Figure 13. Global Q Fever Market Share by Players in 2020
Figure 14. Global Top Q Fever Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Q Fever as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Q Fever Revenue in 2020
Figure 16. Global Q Fever Revenue Market Share by Type (2016-2021)
Figure 17. Global Q Fever Revenue Market Share by Type (2022-2027)
Figure 18. North America Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Q Fever Market Share by Type (2016-2027)
Figure 20. North America Q Fever Market Share by Application (2016-2027)
Figure 21. North America Q Fever Market Share by Country (2016-2027)
Figure 22. United States Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Q Fever Market Share by Type (2016-2027)
Figure 26. Europe Q Fever Market Share by Application (2016-2027)
Figure 27. Europe Q Fever Market Share by Country (2016-2027)
Figure 28. Germany Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Q Fever Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Q Fever Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Q Fever Market Share by Region (2016-2027)
Figure 38. China Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Q Fever Market Share by Type (2016-2027)
Figure 46. Latin America Q Fever Market Share by Application (2016-2027)
Figure 47. Latin America Q Fever Market Share by Country (2016-2027)
Figure 48. Mexico Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Q Fever Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Q Fever Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Q Fever Market Share by Country (2016-2027)
Figure 54. Turkey Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Q Fever Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Yashica Pharmaceuticals Private Limited (India) Revenue Growth Rate in Q Fever Business (2016-2021)
Figure 58. Merck & Co. (US) Revenue Growth Rate in Q Fever Business (2016-2021)
Figure 59. Atox Bio (Israel) Revenue Growth Rate in Q Fever Business (2016-2021)
Figure 60. Teva Pharmaceutical Industries (Israel) Revenue Growth Rate in Q Fever Business (2016-2021)
Figure 61. Basilea Pharmaceutica Ltd. (Switzerland) Revenue Growth Rate in Q Fever Business (2016-2021)
Figure 62. MELINTA THERAPEUTICS(US) Revenue Growth Rate in Q Fever Business (2016-2021)
Figure 63. Pfizer (US) Revenue Growth Rate in Q Fever Business (2016-2021)
Figure 64. Cipla Inc. (India) Revenue Growth Rate in Q Fever Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の周期的発熱症候群市場規模・現状・予測（2021年-2027年） Periodic fever syndrome are a set of disorders characterized by recurrent episodes of systemic and organ-specific inflammation. The syndromes are diverse, but tend to cause episodes of fever, joint pains, skin rashes, abdominal pains and may lead to chronic complications such as amyloidosis. Market …- 世界のリウマチ熱治療市場規模・現状・予測（2021年-2027年） Rheumatic fever is an autoimmune inflammatory disease which can develop as a complication of inadequately treated strep throat. Strep throat is a condition caused by group a Streptococcus bacterium. Rheumatic fever is common in the age group of 5 to 15 years, but adults can also have the condition. …
- 世界のデング熱ウイルス診断検査市場規模・現状・予測（2021年-2027年） Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrom…
- 世界のデング熱ウイルス診断検査市場規模・現状・予測（2021年-2027年） Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrom…
- 世界のデジタル診断市場 2021：企業別、地域別、種類・用途別 The Digital Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…